Valeant CEO "disappointed" in Allergan poison pill - CNBC
April 23, 2014 at 08:03 AM EDT
April 23 (Reuters) - The chief executive officer of Valeant Pharmaceuticals, which made a $47 billion unsolicited offer for competitor Allergan Inc. on Tuesday, said during an interview on CNBC that he was "disappointed" with Allergan's so-called poison pill.